Track: Allergy/Immunology

Biologic Therapies for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) – The use of monoclonal antibodies such as Dupilumab and Omalizumab has revolutionized treatment for severe nasal polyps, offering targeted therapy with promising outcomes.

Advances in Allergen-Specific Immunotherapy – Sublingual and subcutaneous immunotherapy are evolving with personalized treatment plans and novel vaccine formulations that enhance efficacy and patient compliance.

The Role of the Microbiome in Allergic and Immunologic ENT Disorders – Emerging research highlights how gut and nasal microbiota influence immune responses in conditions like allergic rhinitis and sinusitis, paving the way for microbiome-based therapies.

Novel Diagnostic Biomarkers for ENT-Related Allergic Diseases – Identifying reliable biomarkers can improve early diagnosis, predict treatment response, and enable precision medicine in allergy and immunology.

Long COVID and ENT Allergic Manifestations – The lingering effects of COVID-19 include heightened allergic responses, chronic sinusitis, and immune dysregulation, raising new challenges for ENT and immunology specialists.

If you are a specialist in this session, we encourage you to submit abstract of your research and share your expertise with fellow professionals to inspire new ideas and collaborations.

International Conference on ENT and Related Disorders

Track: Allergy/Immunology

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at